|
Breakthrough Therapy Designation further demonstrates excellent clinical profile of DZD9008 (Sunvozertinib) Read more ›› |
By: PR Newswire Association LLC. - 27 Jan 2022
|
Related companies:
Dizal Pharmaceutical Co., Ltd |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 26 Jan 2022
|
Related companies:
Adlai Nortye Biopharma Co.,Ltd. |
Adlai Nortye |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 26 Jan 2022
|
Related companies:
Ascletis Pharma Inc. |
|
|
Telitacicept has become the world's first pSS drug to declare Phase II results Read more ›› |
By: PR Newswire Association LLC. - 26 Jan 2022
|
Related companies:
RemeGen Co., Ltd. |
|
|
Read more ›› |
By: GlobenewsWire - 25 Jan 2022
|
Related companies:
Anpac Technology USA (Anpac Bio) |
AnPac Bio-Medical Science Co., Ltd. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 25 Jan 2022
|
Related companies:
Immvira Co.,Ltd. |
|
|
Telitacicept has become the world's first pSS drug to declare Phase II results Read more ›› |
By: PR Newswire Association LLC. - 25 Jan 2022
|
Related companies:
RemeGen Co., Ltd. |
|
|
Read more ›› |
By: GlobenewsWire - 24 Jan 2022
|
Related companies:
Mustang Investment Consulting (Shanghai) Co., Ltd. |
Mustang Bio |
|
|
Read more ›› |
By: GlobenewsWire - 24 Jan 2022
|
Related companies:
Anpac Technology USA (Anpac Bio) |
AnPac Bio-Medical Science Co., Ltd. |
|
|
Read more ›› |
By: GlobenewsWire - 24 Jan 2022
|
Related companies:
Suzhou Connect Biopharmaceuticals, Ltd. |
Connect Biopharma Holdings Ltd. |
|
|
Read more ›› |
By: GlobenewsWire - 24 Jan 2022
|
|
|
Read more ›› |
By: PR Newswire Association LLC. - 24 Jan 2022
|
Related companies:
Suzhou Kintor Pharmaceuticals, Inc. |
|
|
A transformative donation from the Epstein Family Foundation will accelerate Alzheimer's research at the two universities in a push to find better treatments and a cure Read more ›› |
By: PR Newswire Association LLC. - 24 Jan 2022
|
|
|
-- Approximately 80% of 180 patients with recurrent glioblastoma (rGBM) in the Phase III clinical trial are expected to be randomized and enrolled by the end of December 2022;-- Phase III clinical trial evaluates progression-free survival (PFS) and overall survival (OS) of patients with rGBM;--... Read more ›› |
By: PR Newswire Association LLC. - 23 Jan 2022
|
Related companies:
Ascletis Pharma Inc. |
|
|
Enter the Huge Blue Ocean of Synthetic Biology in Advance;Improve Product Matrix in Medical Aesthetics Field Read more ›› |
By: PR Newswire Association LLC. - 21 Jan 2022
|
Related companies:
Sihuan Pharmaceutical Holdings Group Co., Ltd. |
|
|
Read more ›› |
By: GlobenewsWire - 21 Jan 2022
|
Related companies:
Sichuan Clover Biopharmaceuticals, Inc. |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 20 Jan 2022
|
Related companies:
Hinova Pharmaceuticals Inc. |
|
|
Read more ›› |
By: GlobenewsWire - 20 Jan 2022
|
Related companies:
GenomiCare Biotechnology |
|
|
Read more ›› |
By: PR Newswire Association LLC. - 20 Jan 2022
|
|
|
Read more ›› |
By: GlobenewsWire - 19 Jan 2022
|
Related companies:
Adagene (Suzhou) Limited |
|
|
|